CARL – carlsmed, inc. (US:NASDAQ)
Stock Stats
News
Carlsmed (CARL) had its price target lowered by The Goldman Sachs Group, Inc. from $19.00 to $17.00. They now have a "buy" rating on the stock.
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
Carlsmed (CARL) was upgraded by Zacks Research from "strong sell" to "hold".
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference [Yahoo! Finance]
Carlsmed (CARL) was downgraded by Zacks Research from "hold" to "strong sell".
Form 4 CARLSMED, INC. For: Mar 02 Filed by: Cordonnier Michael
Form 144 CARLSMED, INC. Filed by: Cordonnier Michael
Form S-8 CARLSMED, INC.
Form 10-K CARLSMED, INC. For: Dec 31
Form 8-K CARLSMED, INC. For: Feb 25
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.